Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

381.17
Delayed Data
As of Dec 14
 +2.66 / +0.70%
Today’s Change
281.89
Today|||52-Week Range
416.49
+1.39%
Year-to-Date

Today’s Trading

Previous close378.51
Today’s open382.96
Day’s range379.00 - 386.90
Volume758,430
Average volume (3 months)702,254
Market cap$36.5B
Data as of 4:00pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)+31.81%
Earnings growth (this year)+32.38%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+20.82%
P/E ratio24.4
Price/Sales7.42
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-1.25-1.87%
VRTXVertex Pharmaceutica...-3.36-1.94%
ZTSZoetis Inc-2.49-2.74%
ALXNAlexion Pharmaceutic...-3.00-2.67%
Data as of 4:15pm ET, 12/14/2018

Financials

Next reporting dateFebruary 12, 2019
EPS forecast (this quarter)$5.54
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts